Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
69 hedge funds and large institutions have $64.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 6 closing their positions.
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
3% less funds holding
Funds holding: 71 → 69 (-2)
9% less capital invested
Capital invested by funds: $71.3M → $64.9M (-$6.33M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$885K |
| 2 |
Millennium Management
New York
|
+$391K |
| 3 |
MC
Menta Capital
San Francisco,
California
|
+$286K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$210K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.17M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$671K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$471K |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$358K |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$299K |
SCMP Hedge Fund Activity: Q3 2014 in Review
69 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q3 2014, worth a combined $64.9M — down 8.9% from $71.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SCMP and 4 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 24 added.
The largest buyer was Granahan Investment Management, adding an estimated $885K. The largest seller was TFS Capital, exiting entirely with an estimated $1.17M sold.
- 69 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q3 2014, down from 71 in Q2 2014.
- Funds reported $64.9M of Sucampo Pharmaceuticals, Inc. stock for Q3 2014, down 8.9% quarter-over-quarter.
- 4 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q3 2014 and 6 closed out, a net change of -2 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q3 2014 was Granahan Investment Management, an estimated $885K added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q3 2014 was TFS Capital, an estimated $1.17M sold.
Based on aggregated 13F filings for Q3 2014.